A novel composition for in vitro and in vivo regeneration of skin and connective tissues

Cell Biochemistry and Function

Volumn 29, Issue 4, 2011, Pages 311-333

  Gennero, Luisa ^a   de Siena, Rocco ^b   Denysenko, Tetyana ^a   Roos, Maria Augusta ^c   Calisti, Gian Franco ^d   Martano, Manuela ^b   Fiobellot, Simona ^b   Panzone, Michele ^a   Reguzzi, Stefano ^a   Gabetti, Luisa ^g   Vercelli, Andrea ^e   Cavallo, Giovanni ^a   Ricci, Elia ^f   Pescarmona, Gian Piero ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Consorzio Carso Laboratories ^*  (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Department of Aviation Defence ^*  (Italy)

^e Small Animal Veterinary Clinic   (Italy)

^f Clinica San Luca   (Italy)

^g General Medicine and Pediatrics   (Italy)

Author keywords

Antioxidant agents; Calcium ions; Connective; l carnitine; Polydeoxyribonucleotides (PDRNs); Proteolytic enzymes; Skin; Tissue regeneration

Indexed keywords

CALCIUM ION; CARNITINE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 5; POLYDEOXYRIBONUCLEOTIDE; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL VIABILITY; CONNECTIVE TISSUE; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN BIOPSY; TISSUE CULTURE; TISSUE REGENERATION; TISSUE SECTION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING; ZYMOGRAPHY;

ADMINISTRATION, TOPICAL; ANIMALS; BIOPSY; BODY WEIGHT; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; COLLAGEN TYPE I; COLLAGEN TYPE II; CONNECTIVE TISSUE; CULTURE MEDIA; DIABETES MELLITUS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MICE; POLYDEOXYRIBONUCLEOTIDES; SKIN; STAINING AND LABELING; WOUND HEALING;

MUS;

EID: 79958859589     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1751     Document Type: Article

References (90)

1. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-1072.
2. Griffith LG, Naughton G. Tissue engineering--current challenges and expanding opportunities. Science 2002; 295: 1009-1014.
3. Wagers AJ, Christensen JL, Weissman IL. Cell fate determination from stem cells. Gene Ther 2002; 9: 606-612.
4. Bianco P, Cossu G. Uno, nessuno e centomila: searching for the identity of mesodermal progenitors. Exp Cell Res 1999; 251: 257-263.
5. Grayson WL, Martens TP, Eng GM, Radisic M, Vunjak-Novakovic G. Biomimetic approach to tissue engineering. Semin Cell Dev Biol 2009; 20(6): 665-673.
6. Verrecchia F, Laboureau J, Verola O, et al. Skin involvement in scleroderma--where histological and clinical scores meet. Rheumatology (Oxford) 2007; 46(5): 833-841.
7. Perry DM, McGrouther DA, Bayat A. Current tools for noninvasive objective assessment of skin scars. Plast Reconstr Surg 2010; 126(3): 912-923.
8. Carantino I, Florescu IP, Carantino A. Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment. J Med Life 2010; 3(2): 122-127.
9. Leclère FM, Mordon SR. Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther 2010; 12(5): 227-234.
10. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006; 18: 396-402.
11. Costa AM, Peyrol S, Porto LC, Comparin JP, Foyatier JL, Desmouliere A. Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars. Am J Pathol 1999; 155: 1671-1679.
12. Franke WW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. J Cell Biol 1979; 81: 570-580.
13. Schweizer J, Bowden PE, Coulombe PA, et al. New consensus nomenclature for mammalian keratins. J Cell Biol 2006; 174: 169-174.
14. Miller EJ. A review of biochemical studies on the genetically distinct collagens of skeletal system. Clin Orthop Relat Res 1973; 92: 260-280.
15. Kyriakides TR, Maclauchlan S. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 2009; 3: 215-225.
16. Crook M. Platelet prothrombinase in health and disease. Blood Coagul Fibrinolysis 1990; 1: 167-174.
17. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
18. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002; 161: 831-839.
19. Kyriakides TR, Tam JW, Bornstein P. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 1999; 113: 782-787.
20. Agah A, Kyriakides TR, Letrondo N, Björkblom B, Bornstein P. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 2004; 22: 539-547.
21. Krady MM, Zeng J, Yu J, et al. Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 2008; 173: 879-891.
22. MacLauchlan S, Skokos EA, Agah A, et al. Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem 2009; 57: 301-313.
23. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20: 86-100.
24. Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 2003; 90: 986-992.
25. Velasco P, Huegel R, Brasch J, et al. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol 2009; 129: 2022-2030.
26. Jackson J, Seed M, Kircher C, Willoughby D, Winkler J. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11: 457-465.
27. 4 hydrolase. Br J Pharmacol 2008; 153: 983-991.
28. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007; 8: 221-233.
29. Kyriakides TR, Wulsin D, Skokos EA, et al. Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 2009; 28: 65-73.
30. Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J Biol Chem 2000; 275: 32167-32173.
31. Krady MM, Zeng J, Yu J, et al. Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 2008; 173: 879-891.
32. Kopp HG, Hooper AT, Broekman MJ, et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 2006; 116: 3277-3291.
33. Cotran RS, Kumar V, Collins T, Robbins SL. Tissue Repair: Cellular Growth, Fibrosis and Wound Healing. Robbins Pathologic Basis of Disease 6th ed. WBSaunders Company: Philadelphia, PA, 1999; 89-112.
34. Galeano M, Bitto A, Altavilla D, et al. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen 2008; 16(2): 208-217.
35. Sini P, Denti A, Cattarini G, Daglio M, Tira ME, Balduini C. Effect of polydeoxyribonucleotides on human fibroblasts in primary culture. Cell Biochem Funct 1999; 17: 107-114.
36. Guizzardi S, Galli C, Govoni P, et al. Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci 2003; 73: 1973-1983.
37. Altavilla D, Bitto A, Polito F, et al. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Cardiovasc Hematol Agents Med Chem 2009; 7: 313-321.
38. Akkus A, Aydinuraz K, Daphan C, et al. Effect of carnitine on cutaneous wound healing in immunosuppressed rats. J Surg Res 2009; 155(2): 301-305.
39. Wyss V, Ganzit GP, Rienzi A. Effects of l-carnitine administration on VO2max and the aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol 1990; 60(1): 1-6.
40. Nakano Y, Kuroda E, Kito T, Yokota A, Yamashita U. Induction of macrophagic prostaglandin E2 synthesis by glioma cells. J Neurosurg 2006; 104: 574-582.
41. Marjoram RJ, Voss B, Pan Y, et al. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen. J Biol Chem 2009; 284: 34640-34647.
42. Hurtado M, Lozano JJ, Castellanos E, et al. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut 2007; 56: 1266-1274.
43. Langer HF, Gawaz M. Platelets in regenerative medicine. Basic Res Cardiol 2008; 103: 299-307.
44. Aguirre A, González A, Planell JA, Engel E. Extracellular calcium modulates in vitro bone marrow-derived Flk-1+ CD34+ progenitor cell chemotaxis and differentiation through a calcium-sensing receptor. Biochem Biophys Res Commun 2010; 393: 156-161.
45. Insall RH. Understanding eukaryotic chemotaxis: a pseudopod-centred view. Nat Rev Mol Cell Biol 2010; 11: 453-458.
46. Schneider L, Cammer M, Lehman J, et al. Directional cell migration and chemotaxis in wound healing response to PDGF-AA are coordinated by the primary cilium in fibroblasts. Cell Physiol Biochem 2010; 25: 279-292.
47. Yoshino H, Takahashi K, Monzen S, Kashiwakura I. Proteoglycans regulate the chemotaxis of dendritic cells derived from human peripheral blood monocytes. Biol Pharm Bull 2010; 33: 938-944.
48. Quintanar-Guerrero D, Ganem-Quintanar A, Tapia-Olguín P, Kalia YN, Buri P. The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail. Drug Dev Ind Pharm 1998; 24: 685-690.
49. Lazorthes Y, Richaud J, Roger B, Lagarrigue J, Verdie JC, Bonafe A. Chemonucleolysis in the treatment of surgical sciatica. Neurochirurgie 1985; 31: 471-493.
50. da Silva CR, Oliveira MB, Motta ES, et al. Genotoxic and cytotoxic safety evaluation of papain (Carica papaya L.) using in vitro assays. J Biomed Biotechnol 2010; 2010: 197898-197908.
51. Robinson M, Reynolds AJ, Gharzi A, Jahoda CA. In vivo induction of hair growth by dermal cells isolated from hair follicles after extended organ culture. J Invest Dermatol 2001; 117: 596-604.
52. Smith JR, Venable S, Roberts TW, Metter EJ, Monticone R, Schneider EL. Relationship between in vivo age and in vitro aging: assessment of 669 cell cultures derived from members of the Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci 2002; 57: 239-246.
53. Buhl, AE, Waldon, DJ, Kawabe, TT, Holland, MJ. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 1989; 92: 315-320.
54. Philpott, MP, Green, MR, Kealey, T. Human hair growth in vitro. J Cell Sci 1990; 97: 463-471.
55. Philpott, MP, Green, MR, Kealey, T. Rat hair follicle growth in vitro. Br J Dermatol 1992; 127: 600-607.
56. Westgate, GE, Gibson, WT, Kealey, T, Philpott, MP. Prolonged maintenance of human hair follicles in vitro in a serum free medium. Br J Dermatol 1993; 129: 372-379.
57. Muratore O, Pesce Schito A, Cattarini G, et al. Evaluation of the trophic effect of human placental polydeoxyribonucleotide on human knee skin fibroblasts in primary culture. Cell Mol Life Sci 1997; 53: 279-285.
58. Galeano M, Bitto A, Altavilla D, et al. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen 2008; 16: 208-217.
59. Arslan E, Milcan A, Unal S, et al. The effects of carnitine on distally-burned dorsal skin flap: an experimental study in rats. Burns 2003; 29: 221-227.
60. Akkus A, Aydinuraz K, Daphan C, et al. Effect of carnitine on cutaneous wound healing in immunosuppressed rats. J Surg Res 2009; 155: 301-305.
61. Arslan E, Basterzi Y, Aksoy A, et al. The additive effects of carnitine and ascorbic acid on distally burned dorsal skin flap in rats. Med Sci Monit 2005; 11: 176-180.
62. Scarano A, Carinci F, Cimorelli E, Quaranta M, Piattelli A. Application of calcium sulfate in surgical-orthodontic treatment of impacted teeth: a new procedure to control hemostasis. J Oral Maxillofac Surg 2010; 68: 964-968.
63. Ou K, Liu Y, Zhang L, et al. Effect of neutrase, alcalase, and papain hydrolysis of whey protein concentrates on iron uptake by Caco-2 cells. J Agric Food Chem 2010; 58: 4894-4900.
64. Lima CC, Pereira AP, Silva JR, et al. Ascorbic acid for the healing of skin wounds in rats. Braz J Biol 2009; 69: 1195-1201.
65. Ziosi P, Besco E, Vertuani S, Solaroli N, Manfredini S. A non-invasive method for the in vivo determination of skin antioxidant capacity (IAC-S). Skin Res Technol 2006; 12: 303-308.
66. Corsi L. Effects of the novel non-peptidyl low molecular weight radical scavenger IAC in different models of inflammation: a new perspective in anti- inflammatory therapy. Curr Med Chem 2010; 17: 3918-3924.
67. Mancarella R, Del Guerra S, Masini M, et al. Beneficial effect of the nonpeptidyl low molecular weight radical scavenger IAC on cultured human islet function. Cell Transplant 2008; 17: 1271-1276.
68. Novelli M, D'Aleo V, Lupi R, et al. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Pancreas 2007; 35: e10-e17.
69. Vasina V, Broccoli M, Ursino MG, et al. Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. Eur J Pharmacol 2009; 614: 137-145.
70. Canistro D, Affatato AA, Soleti A, et al. The novel radical scavenger IAC is effective in preventing and protecting against post-ischemic brain damage in Mongolian gerbils. J Neurol Sci 2010; 290: 90-95.
71. Zavatti M, Corsi L, Zanoli P, Baraldi M. Anti-ulcer activity of IAC, a novel free-radical scavenger, in rats. J Pharm Pharmacol 2009; 61: 395-397.
72. Castro-Garza J, Barrios-García HB, Cruz-Vega DE, et al. Use of a colorimetric assay to measure differences in cytotoxicity of Mycobacterium tuberculosis strains. J Med Microbiol 2007; 56: 733-737.
73. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. Anal Biochem 1980; 102: 196-202.
74. Madison KC. Barrier function of the skin: "la raison d'être" of the epidermis. J Invest Dermatol 2003; 121: 231-241.
75. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004; 36(6): 1031-1037.
76. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
77. Lambert V, Wielockx B, Munaut C, et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003; 17(15): 2290-2292.
78. DeNiro M, Al-Halafi A, Al-Mohanna FH, Alsmadi O and Al-Mohanna FA. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol Pharmacol 2010; 77(3): 348-367.
79. Fang L, Teuchert M, Huber-Abel F, et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci 2010; 294(1-2): 51-56.
80. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Investig Dermatol 1993; 101: 64-68.
81. Bayer IM, Adamson SL, Langille BL. Atrophic remodeling of the artery-cuffed artery. Arterioscler Thromb Vasc Biol 1999; 19(6): 1499-1505.
82. Justulin Jr LA, Della-Coleta HH, Taboga SR, Felisbino SL. Matrix metalloproteinase (MMP)-2 and MMP-9 activity and localization during ventral prostate atrophy and regrowth. Int J Androl 2010; 33(5): 696-708.
83. Moalli PA, Klingensmith WL, Meyn LA. Increased expression of matrix metalloproteinases in the uterine cervix of postmenopausal women. J Low Genit Tract Dis 2003; 7(1): 36-43.
84. Reznick AZ, Menashe O, Bar-Shai M, Coleman R, Carmeli E. Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats. Muscle Nerve 2003; 27(1): 51-59.
85. Hovdenak N, Wang J, Sung CC, Kelly T, Fajardo LF, Hauer-Jensen M. Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53(4): 919-927.
86. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100-107.
87. Prager R. Pathogenesis and therapy of type I and type II diabetes mellitus. Wien Med Wochenschr 1988; 138(14): 337-340.
88. Seaquist ER, Ibrahim HN. Approach to the patient with type 2 diabetes and progressive kidney disease. J Clin Endocrinol Metab 2010; 95(7): 3103-3110.
89. Berchtold P, Sims EA, Horton ES, Berger M. Obesity and hypertension: epidemiology, mechanisms, treatment. Biomed Pharmacother 1983; 37: 251-258.
90. Belsare PV, Watve MG, Ghaskadbi SS, Bhat DS, Yajnik CS, Jog M. Metabolic syndrome: aggression control mechanisms gone out of control. Med Hypotheses 2010; 74(3): 578-589.